A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke

Seminars in Thrombosis and Hemostasis

Volumn 16, Issue SUPPL., 1990, Pages 25-33

  Sandset, P M ^a   Dahl, T ^a   Stiris, M ^a   Rostad, B ^a   Scheel, B ^a   Abildgaard, U ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; BRAIN HEMORRHAGE; CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FACTOR XA; FEMALE; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; SUPPORT, NON-U.S. GOV'T; THROMBOPHLEBITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0025254642     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)